eczema drug
-
FDA approved Sanofi’s eczema drug Dupixent
Oct 20, 2018France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma. Dupixent, co-developed with U.S.-based Regeneron, received...
